2022

Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform May 5, 2022, Click here for the link to the paper in Toxicologic Pathology

Vaccines – The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines January 20, 2022 Click here for the link to the paper in Analytical and Bioanalytical Chemistry

Science Direct, January 19, 2022 A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice
Click here for the link to the full article